Skip to main content
Phaarmasia Limited. logo

Phaarmasia Limited. — Investor Relations & Filings

Ticker · 523620 ISIN · INE486I01016 BSE.NS Manufacturing
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-06-01 Earnings Release
Country IN India
Listing BSE.NS 523620

About Phaarmasia Limited.

https://phaarmasia.in/

Phaarmasia Limited specializes in the development, manufacture, and marketing of a diverse range of pharmaceutical formulations. The company operates advanced manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, ointments, creams, and liquid orals. Its core business model encompasses both the production of proprietary brands and strategic contract manufacturing services for global and domestic entities. Phaarmasia focuses on multiple therapeutic segments such as dermatology, gastroenterology, and general medicine. The company maintains rigorous quality standards, adhering to Good Manufacturing Practices (GMP) to ensure the safety and efficacy of its products. By leveraging technical expertise and scalable production capabilities, Phaarmasia serves as a key partner in the supply chain, catering to diverse healthcare needs through high-quality medicinal solutions.

Recent filings

Filing Released Lang Actions
Newspaper Advertisement of the Audited Financial Results for the Quarter and year ended 31st March 2026
Earnings Release Classification · 85% confidence The document is a compliance submission to BSE under SEBI LODR Regulation 47, enclosing the newspaper advertisement of the audited financial results for the quarter and year ended 31 March 2026. It contains only key financial highlights (total income, revenue, profit, etc.) in a tabular advertisement format, not the full financial statements. This matches the definition of an Earnings Release (initial announcement of quarterly/periodical financial results with key highlights). It is not an Annual Report, full interim report, or mere publication notice of a separate report. Therefore, it is classified as an Earnings Release. FY 2026
2026-06-01 English
Submission of Integrated Filing of Financials for the Quarter and FY ended 31st March, 2026
Interim / Quarterly Report Classification · 88% confidence The document is a regulatory filing to BSE of audited financial results for the quarter and year ended 31 March 2026, complete with actual financial statements and the independent auditor’s report. It contains comprehensive interim/quarterly financial data (quarter ended results) along with year-end figures and an audit report, satisfying the definition of an Interim / Quarterly Report. It is not merely an announcement of availability nor a full annual report, so it should be classified as IR. FY 2026
2026-05-29 English
Submission of Financial Results for the Quarter and FY ended 31st March, 2026
Interim / Quarterly Report Classification · 88% confidence The document is a formal BSE listing submission of the audited financial results for the quarter and year ended 31 March 2026 under Regulation 33 of SEBI (LODR). It contains full interim financial statements, audit opinions, and auditor’s report—far beyond a mere earnings highlight. It is not a full annual report (10-K) but a comprehensive interim/quarterly report with substantive financial data and audit sign-off. Therefore it best fits the Interim/Quarterly Report category. FY 2026
2026-05-29 English
Pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we would like to inform you that the meeting of Board of Directors ....
Regulatory Filings Classification · 85% confidence The document is a “Board Meeting Outcome” notice filed under SEBI LODR to BSE’s Listing Compliance Department. It does not include the actual financial statements or auditor’s report, nor does it propose a new director/senior management change. Instead, it simply announces approvals (audited results, auditor appointments) from the board meeting. This is a general regulatory announcement that does not fit a specific category like an Annual Report, Interim Report, or Management Change, so it falls into the fallback “Regulatory Filings” category.
2026-05-29 English
Phaarmasia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider, review, approve, ....
Regulatory Filings Classification · 78% confidence The document is a notice under SEBI LODR to the stock exchange informing of an upcoming Board meeting to review and approve financial results and auditor appointments. It does not itself contain the financial results or management change, nor is it a direct publication of a report; rather, it is a general regulatory announcement. This fits best under the catch-all “Regulatory Filings” category (RNS).
2026-05-22 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.